Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long Term Safety Study of the Vascular Wrap(TM) Paclitaxel-Eluting Mesh After Surgical Implantation With the Lifespan® Graft in the Upper Extremity for Hemodialysis Vascular Access

NCT01033357 is registered in ClinicalTrials.gov with Angiotech Pharmaceuticals as lead sponsor.

NCT NCT01033357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01033357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long Term Safety Study of the Vascular Wrap(TM) Paclitaxel-Eluting Mesh After Surgical Implantation With the Lifespan® Graft in the Upper Extremity for Hemodialysis Vascular Access
Lead sponsor
Angiotech Pharmaceuticals
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2008
Completion date
October 31, 2010
Enrollment
222 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal failure on dialysis, hyperplasia